VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Demineralized Dentin Matrix
Preclinical
Biologic
C
Cairo University
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Socket Preservation
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Socket Preservation
Preclinical
Completed
Clinical
Trials by Indication
[1]
Allograft
1 trial
Evaluation of Amnion Chorion Membrane and Demineralized Bone Matrix Putty Allograft in Periodontal Intrabony Defects
Completed
·
—
·
N/A
·
NCT02679209
·
22 enrolled
Socket Preservation
1 trial
Evaluation of Post Extraction Hard Tissue Alteration Following Ridge Preservation in the Esthetic Zone Using Allogeneic Dentin Matrix Versus Demineralized Freeze-Dried Bone Allograft: A Randomized Controlled Clinical Trial
Completed
·
C
Cairo University
·
Preclinical
·
NCT06318650
·
22 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Demineralized Dentin Matrix. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Demineralized Dentin Matrix compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Demineralized Dentin Matrix. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Cairo University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
C
Cairo University
Related News